Patient Characteristics Associated With Severe Hypoglycemia in a Type 2 Diabetes Cohort in a Large, Integrated Health Care System From 2006 to 2015
The DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.
Abstract
Objective To identify severe hypoglycemia events, defined as emergency department visits or hospitalizations for hypoglycemia, in patients with type 2 diabetes receiving care in a large health system and to identify patient characteristics associated with severe hypoglycemia events. Research design and methods This was a retrospective cohort study from January 2006 to December 2015 using the electronic medical record in the Cleveland Clinic Health System (CCHS). Participants included 50,439 patients with type 2 diabetes receiving care in the CCHS. Number of severe hypoglycemia events and associated patient characteristics were identified. Results The incidence proportion of severe hypoglycemia increased from 0.12% in 2006 to 0.31% in 2015 ( P = 0.01). Compared with patients who did not experience severe hypoglycemia, those with severe hypoglycemia had similar median glycosylated hemoglobin (HbA 1c ) levels. More patients with severe hypoglycemia versus those without had a prior diagnosis of nonsevere hypoglycemia (9% vs. 2%, P P 1c P Conclusions In this retrospective study of patients with type 2 diabetes with severe hypoglycemia, patient characteristics were identified. Patients with severe hypoglycemia had previous nonsevere hypoglycemia diagnoses more frequently than those without. Identifying patients at high risk at the point of care can allow for change in modifiable risk factors and prevention of severe hypoglycemia events.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751 · cited 1×
“SH ED visits 3 (38) 2 (29) 2 (29) 4 (12) 3 (7) 4 (9) 7 (10) 5 (6) 4 (4) 12 (12)”
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Validation of a combined comorbidity index
Charlson, M., Szatrowski, T. P., Peterson, J., & Gold, J. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90129-5 · Cited by 6,587
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Severe hypoglycemia and risks of vascular events and death
Zoungas, S., Patel, A., Chalmers, J., de Galan, B. E., Li, Q., Billot, L., Woodward, M., Ninomiya, T., Neal, B., MacMahon, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003795 · Cited by 1,471
Cited by
6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s006 · Cited by 486
6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s006 · Cited by 440
Silbert, R., Salcido-Montenegro, A., Rodriguez-Gutierrez, R., Katabi, A., & McCoy, R. G. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1018-0 · Cited by 229
“[5, 77 , 78, 83] Importantly, while sulfonylurea and insulin medications do carry the highest risk of hypoglycemia, they can be used safely and should not be avoided if clinically necessary.”
Influential6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026.
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s006 · Cited by 172
McCoy, R. G., Lipska, K. J., Van Houten, H. K., & Shah, N. D. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.19099 · Cited by 141
Elhussein, A., Anderson, A., Bancks, M. P., Coday, M., Knowler, W. C., Peters, A., Vaughan, E. M., Maruthur, N. M., Clark, J. M., & Pilla, S. (2022) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2021.100111 · Cited by 92
Le, P., Chaitoff, A., Misra-Hebert, A. D., Ye, W., Herman, W. H., & Rothberg, M. B. (2020) · Diabetes Care · doi:10.2337/dc19-2424 · Cited by 82
Self-citationForlenza, G. P., Carlson, A. L., Galindo, R. J., Kruger, D. F., Levy, C. J., McGill, J. B., Umpierrez, G., & Aleppo, G. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0206 · Cited by 70
van Meijel, L. A., de Vegt, F., Abbink, E. J., Rutters, F., Schram, M. T., van der Klauw, M. M., Wolffenbuttel, B. H. R., Siegelaar, S., DeVries, J. H., Sijbrands, E. J. G., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000935 · Cited by 68
Tibaldi, J., Hadley‐Brown, M., Liebl, A., Haldrup, S., Sandberg, V., Wolden, M. L., & Rodbard, H. W. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13616 · Cited by 46
Nishioka, Y., Okada, S., Noda, T., Myojin, T., Kubo, S., Ohtera, S., Kato, G., Kuroda, T., Ishii, H., & Imamura, T. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13153 · Cited by 28
Barrea, L., Vetrani, C., Caprio, M., Ghoch, M. E., Frías-Toral, E., Mehta, R. J., Méndez, V., Moriconi, E., Paschou, S. Α., Pazderska, A., et al. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1980766 · Cited by 34
Sala, L. L., & Pontiroli, A. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910643 · Cited by 29
Lee, J., Kim, Y., Han, K., Han, E., Lee, B., Kang, E. S., Soo, B., Ko, S., & Lee, Y. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.0262 · Cited by 26
Hypoglycemia communication in primary care visits for patients with diabetes
Pilla, S. J., Park, J., Schwartz, J. L., Albert, M. C., Ephraim, P. L., Boulware, L. E., Mathioudakis, N. N., Maruthur, N. M., Beach, M. C., & Greer, R. C. (2021) · Journal of General Internal Medicine · doi:10.1007/s11606-020-06385-x · Cited by 23
Approaches to risk assessment among older patients with diabetes
Pilla, S. J., Schoenborn, N. L., Maruthur, N. M., & Huang, E. S. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1172-z · Cited by 24
Hypoglycaemia and its management in primary care setting
Ibrahim, M., Baker, J., Cahn, A., Eckel, R. H., El Sayed, N. A., Fischl, A. H., Gaede, P., Leslie, R. D., Pieralice, S., Tuccinardi, D., et al. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3332 · Cited by 21
Severe Hypoglycemia Attributable to Intensive Glucose-Lowering Therapy Among US Adults With Diabetes
Mahoney, G. K., Henk, H. J., & McCoy, R. G. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2019.02.028 · Cited by 26
Petroni, M. L., Montesi, L., Colosimo, S., Caletti, M. T., Mazzotti, A., & Marchesini, G. (2019) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.82 · Cited by 19
Zhang, Q., Hu, S., Jin, Z., Wang, S., Zhang, B., & Zhao, L. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1339148 · Cited by 21
Misra‐Hebert, A. D., Ji, X., Pantalone, K. M., Hu, B., Dey, T., Milinovich, A., Bauman, J. M., Zimmerman, R. S., & Kattan, M. W. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2019.107490 · Cited by 18
Self-citationPilla, S. J., Kraschnewski, J. L., Lehman, E. B., Kong, L., Francis, E., Poger, J. M., Bryce, C. L., Maruthur, N. M., & Yeh, H.-C. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002153 · Cited by 16
Identifying Common Predictors of Multiple Adverse Outcomes Among Elderly Adults With Type-2 Diabetes
Kabue, S., Liu, V. X., Dyer, W., Raebel, M. A., Nichols, G. A., & Schmittdiel, J. A. (2019) · Medical Care · doi:10.1097/mlr.0000000000001159 · Cited by 17
Diabetes: how to manage patients experiencing hypoglycaemia
Lowe, R. N., Williams, B., & Claus, L. W. (2022) · Drugs in Context · doi:10.7573/dic.2021-9-11 · Cited by 27
Misra‐Hebert, A. D., Milinovich, A., Zajichek, A., Ji, X., Hobbs, T. D., Weng, W., Petraro, P., Kong, S. X., Mocarski, M., Ganguly, R., et al. (2020) · Diabetes Care · doi:10.2337/dc19-1791 · Cited by 14
Self-citationLega, I. C., Yale, J.-F., Chadha, A., Paty, B., Roscoe, R., Snider, M., Steier, J., Bajaj, H. S., Barnes, T., Gilbert, J., et al. (2023) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2023.08.003 · Cited by 12
“Insulin and insulin secretagogue therapy confer the highest risk of hypoglycemia compared to other antihyperglycemic agents [1,3,35,36], especially among high-risk groups, such as older adults, those with cognitive impairment, and individuals treated to intensive glycemic targets (see “ Blood…”
BackgroundYun, J., Han, K., & Ko, S. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13786 · Cited by 11
Yun, J., Han, K., Park, Y., Han, E., Lee, Y., & Ko, S. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13818 · Cited by 16
Mylona, M., Liatis, S., Anastasiadis, G., Kapelios, C. J., & Kokkinos, A. D. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108038 · Cited by 10
Lee, Y. H. (2020) · Yonsei Medical Journal · doi:10.3349/ymj.2020.61.2.169 · Cited by 9
Vonna, A., Salahudeen, M. S., & Peterson, G. M. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13020530 · Cited by 11
Weiner, M., Cummins, J., Raji, A., Ofner, S., Iglay, K., Teal, E. Y., Li, X., Engel, S. S., Knapp, K., Rajpathak, S. N., et al. (2020) · Current Medical Research and Opinion · doi:10.1080/03007995.2020.1717451 · Cited by 8
Grady, M., Cameron, H., & Holt, E. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01415-3 · Cited by 6
van Mark, G., Lanzinger, S., Sziegoleit, S., Putz, F. J., Durmaz, M., Borscheller, M., Danne, T., Seufert, J., Holl, R. W., & Bramlage, P. (2019) · Advances in Therapy · doi:10.1007/s12325-019-00983-w · Cited by 7
He, Y., Kunutsor, S. K., Kingsnorth, A. P., Gillies, C., Choudhary, P., Khunti, K., & Zaccardi, F. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15677 · Cited by 5
“16,17,21 19 Identification of shared and unique risk factors for these outcomes would be critical for predicting and preventing hypoglycaemia and its complications in individual patients.”
Trends and Disparities in Rates of Hypoglycemia Among Hospitalized Patients With Type 2 Diabetes
Heidenreich, P. A., Lin, S., Gallo, R. J., Sahay, A. P., Burkhardt, M. E., Glassman, P. A., Fang, D. Z., & Moore, V. R. (2025) · Diabetes Care · doi:10.2337/dc24-1539 · Cited by 6
A general view of epidemiology of hypoglycemia in type 1 and type 2 diabetes mellitus
Brož, J., & Urbanová, J. (2019) · Vnitřní lékařství · doi:10.36290/vnl.2019.050 · Cited by 5
Sulfonylurea derivatives and risk of hypoglycaemia in type 2 diabetic patients
Svěcený, J., Jirušková, J., Hrach, K., Radovnická, L., & Laštůvka, J. (2020) · Vnitřní lékařství · doi:10.36290/vnl.2020.114 · Cited by 6
Butzlaff, A., & Moore, D. J. (2023) · Nursing Made Incredibly Easy! · doi:10.1097/01.nme.0000936392.15189.21 · Cited by 3
LACY, M. E., Whitmer, R. A., Lee, S. J., Rushakoff, R. J., & Pletcher, M. J. (2021) · Clinical Diabetes · doi:10.2337/cd20-0057 · Cited by 1
Endocrinology and Diabetes in the Elder
Levy, D. E. (2020) · Cambridge University Press eBooks · doi:10.1017/9781316823040.027
Ko, S. (2022) · Cardiovascular Prevention and Pharmacotherapy · doi:10.36011/cpp.2022.4.e13 · Cited by 1
Alabbas, S. A., Jiang, R., Au, A., Vu, M., Moore, V. R., Cunningham, F. E., Stroupe, K. T., Bounthavong, M., Glassman, P. A., Good, C. B., et al. (2023) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxad060
Recurrent Hypoglycaemia in A Diabetic Patient: The Unexpected Diagnosis
Ooi, P. S., Draman, N., Mustaffa, N., & Jamani, N. A. (2023) · IIUM Medical Journal Malaysia · doi:10.31436/imjm.v22i4.2151
“11 As primary care physicians, we play a crucial role in identifying those patients at risk of hypoglycaemia and properly managing them, especially in those with underlying liver diseases.”
Li, L., Liu, S., & Yang, P. C. (2024) · Research Square · doi:10.21203/rs.3.rs-4610003/v1
Medications for the Management of Hypoglycemia
Giruzzi, M. E. (2025) · American Diabetes Association eBooks · doi:10.2337/9781580408462-ch28
Metadata
- Authors
- Misra-Hebert, A. D., Pantalone, K. M., Ji, X., Milinovich, A., Dey, T., Chagin, K. M., Bauman, J. M., Kattan, M. W., & Zimmerman, R. S.
- Affiliations
- Department of Internal Medicine and Center for Value-Based Care Research, Medicine Institute, Cleveland Clinic, Cleveland, OH
- Cleveland Clinic (US)
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2018-03-16
- Volume
- 41
- Issue
- 6
- Pages
- 1164-1171
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2792557235
- Cited by
- 46
- References
- 37
- Citations by year
- 2025: 3 · 2024: 5 · 2023: 6 · 2022: 6 · 2021: 6 · 2020: 10 · 2019: 8 · 2018: 2
- FWCI
- 5.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Agency for Healthcare Research and Quality (K08HS024128)
- Merck Investigators Studies Program (MERCK1702AMH)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Patient Safety and Medication Errors
- Keywords
- severe hypoglycemia, type 2 diabetes, risk factors, insulin, sulfonylureas, HbA1c, metformin, DPP-4 inhibitors, GLP-1 receptor agonists, comorbidities, race, body mass index, hypoglycemia prevention
- MeSH terms
- Aged, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Hospitalization, Humans, Hypoglycemia, Hypoglycemic Agents, Insulin, Male, Metformin, Middle Aged, Retrospective Studies, Risk Factors, Severity of Illness Index, Sulfonylurea Compounds, Incidence, Delivery of Health Care, Integrated, Dipeptidyl-Peptidase IV Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.